Literature DB >> 32947222

Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study.

Stephanie L Harrison1, Deirdre A Lane2, Maciej Banach3, Mirosław Mastej4, Sławomir Kasperczyk5, Jacek J Jóźwiak6, Gregory Y H Lip2.   

Abstract

BACKGROUND AND AIMS: An inverse relationship between lipid levels and atrial fibrillation (AF) has been suggested, but whether the association is upheld for all age groups remains unclear. The aim of the study was to examine associations between lipid levels and AF by age groups in a nationwide study in Poland.
METHODS: Multivariate Poisson regression models were used to estimate prevalence ratios (PRs) for AF by lipid levels. Low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), total cholesterol (TC), non-HDL-C and LDL-C/HDL-C ratios were grouped into quartiles.
RESULTS: Of the 13,724 participants, 5.2% (n = 708) had AF. People with AF were older with more comorbidities, but lower lipid levels (all p < 0.05). The prevalence of AF was inversely associated with LDL-C (Adjusted PR (95% Confidence Interval) highest versus lowest quartile: 0.60 (0.48, 0.75)), TC (0.61 (0.49, 0.75)) and non-HDL-C (0.63 (0.51, 0.78)). The prevalence of AF was inversely associated with HDL-C (0.58 (0.46, 0.74)), but this was not statistically significant for people aged 75 years and older. For the LDL-C/HDL-C ratio, the prevalence of AF was only inversely associated with higher levels for people aged 75 years and older (0.75 (0.61, 0.94)). There was no statistically significant difference in prevalence of AF by TG levels.
CONCLUSIONS: The results suggest an inverse relationship between lipid levels and AF. The inverse association between higher HDL-C and AF was only significant for people aged <75 years, whereas the inverse association between higher LDL-C/HDL-C ratio and AF was only significant for people aged 75 years and older.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age; Atrial fibrillation; Cholesterol; Epidemiology; Lipids; Prevalence

Mesh:

Substances:

Year:  2020        PMID: 32947222     DOI: 10.1016/j.atherosclerosis.2020.08.026

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.

Authors:  Maciej Banach; Paweł Burchardt; Krzysztof Chlebus; Piotr Dobrowolski; Dariusz Dudek; Krzysztof Dyrbuś; Mariusz Gąsior; Piotr Jankowski; Jacek Jóźwiak; Longina Kłosiewicz-Latoszek; Irina Kowalska; Maciej Małecki; Aleksander Prejbisz; Michał Rakowski; Jacek Rysz; Bogdan Solnica; Dariusz Sitkiewicz; Grażyna Sygitowicz; Grażyna Sypniewska; Tomasz Tomasik; Adam Windak; Dorota Zozulińska-Ziółkiewicz; Barbara Cybulska
Journal:  Arch Med Sci       Date:  2021-11-08       Impact factor: 3.318

2.  Association between serum apolipoprotein B and atrial fibrillation: a case-control study.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

3.  Influencing Factors of Recurrence of Nonvalvular Atrial Fibrillation after Radiofrequency Catheter Ablation and Construction of Clinical Nomogram Prediction Model.

Authors:  Zhong-Bao Ruan; Hong-Xia Liang; Fei Wang; Ge-Cai Chen; Jun-Guo Zhu; Yin Ren; Li Zhu
Journal:  Int J Clin Pract       Date:  2022-03-15       Impact factor: 3.149

4.  Association of atrial arrhythmias with thrombospondin-1 in patients with acute myocardial infarction.

Authors:  Wenkai Liao; Li Xu; Yuxia Pan; Jie Wei; Peijia Wang; Xinchun Yang; Mulei Chen; Yuanfeng Gao
Journal:  BMC Cardiovasc Disord       Date:  2021-10-20       Impact factor: 2.298

5.  Predicting Values of Neutrophil-to-Lymphocyte Ratio (NLR), High-Sensitivity C-Reactive Protein (hs-CRP), and Left Atrial Diameter (LAD) in Patients with Nonvalvular Atrial Fibrillation Recurrence After Radiofrequency Ablation.

Authors:  Bing Ding; Pengfei Liu; Fangfang Zhang; Jie Hui; Linyan He
Journal:  Med Sci Monit       Date:  2022-01-27

6.  Lipid levels in midlife and risk of atrial fibrillation over 3 decades-Experience from the Swedish AMORIS cohort: A cohort study.

Authors:  Mozhu Ding; Alexandra Wennberg; Bruna Gigante; Göran Walldius; Niklas Hammar; Karin Modig
Journal:  PLoS Med       Date:  2022-08-11       Impact factor: 11.613

7.  Lipids and atrial fibrillation: New insights into a paradox.

Authors:  Dimitrios Sagris; Stephanie L Harrison; Gregory Y H Lip
Journal:  PLoS Med       Date:  2022-08-11       Impact factor: 11.613

Review 8.  Relationship between lipoproteins, thrombosis, and atrial fibrillation.

Authors:  Wern Yew Ding; Majd B Protty; Ian G Davies; Gregory Y H Lip
Journal:  Cardiovasc Res       Date:  2022-02-21       Impact factor: 10.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.